TrialNeurology2025

Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease.

Joshua D Grill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.